 BENSALEM, Pa.--BUSINESS WIRE--- TLIS CLASSACTION--Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation Talis or the Company NASDAQ: TLIS investors concerning the Company and its officers possible violations of federal securities laws. On August 10, 2021, Talis reported its second quarter 2021 financial results. During the related conference call, the Company revealed that its development timelines have been extended by delays in the launching of Talis 